CD274 and neoplasm: Lung cancer treatment guidelines recommend the selection of therapeutic agents based on the genetic mutation of the tumor tissue and programmed death ligand 1 (PD-L1) expression [2]; therefore, tumor tissue sampling is becoming increasingly important.